ET -- US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines , which could have fetched the Indian firm USD 100 million over a period of five years.
ET -- US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines , which could have fetched the Indian firm USD 100 million over a period of five years.
